Artelo Biosciences, Inc. (ARTL) Press Releases https://ir.artelobio.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/artelobio/files/theme/images/logo-sm.png Artelo Biosciences, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Artelo Biosciences Announces Reverse Stock Split]]> https://ir.artelobio.com/news-events/press-releases/detail/177/artelo-biosciences-announces-reverse-stock-split Fri, 06 Mar 26 08:00:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/177/artelo-biosciences-announces-reverse-stock-split <![CDATA[Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results]]> https://ir.artelobio.com/news-events/press-releases/detail/176/artelo-biosciences-provides-business-update-highlighting Tue, 24 Feb 26 08:00:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/176/artelo-biosciences-provides-business-update-highlighting <![CDATA[Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate]]> https://ir.artelobio.com/news-events/press-releases/detail/175/artelo-bioscience-commends-presidential-executive-order Tue, 23 Dec 25 09:00:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/175/artelo-bioscience-commends-presidential-executive-order <![CDATA[Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical Models]]> https://ir.artelobio.com/news-events/press-releases/detail/174/artelo-biosciences-announces-publication-of-new Wed, 03 Dec 25 08:30:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/174/artelo-biosciences-announces-publication-of-new <![CDATA[Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results]]> https://ir.artelobio.com/news-events/press-releases/detail/173/artelo-biosciences-provides-business-update-and-reports Wed, 12 Nov 25 08:00:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/173/artelo-biosciences-provides-business-update-and-reports <![CDATA[Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer]]> https://ir.artelobio.com/news-events/press-releases/detail/172/artelo-biosciences-announces-publication-of-peer-reviewed Tue, 04 Nov 25 08:30:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/172/artelo-biosciences-announces-publication-of-peer-reviewed <![CDATA[Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer]]> https://ir.artelobio.com/news-events/press-releases/detail/171/artelo-biosciences-names-veteran-life-sciences-executive Mon, 27 Oct 25 08:00:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/171/artelo-biosciences-names-veteran-life-sciences-executive <![CDATA[Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit]]> https://ir.artelobio.com/news-events/press-releases/detail/170/artelo-biosciences-announces-expanded-clinical-data-to-be Wed, 15 Oct 25 09:15:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/170/artelo-biosciences-announces-expanded-clinical-data-to-be <![CDATA[Artelo Biosciences Announces Closing of $2.0 Million Public Offering]]> https://ir.artelobio.com/news-events/press-releases/detail/169/artelo-biosciences-announces-closing-of-2-0-million-public Wed, 01 Oct 25 16:05:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/169/artelo-biosciences-announces-closing-of-2-0-million-public <![CDATA[Artelo Biosciences Announces Pricing of $2.0 Million Public Offering]]> https://ir.artelobio.com/news-events/press-releases/detail/168/artelo-biosciences-announces-pricing-of-2-0-million-public Tue, 30 Sep 25 08:30:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/168/artelo-biosciences-announces-pricing-of-2-0-million-public